NRX Pharmaceuticals, Inc. Long-term Debt, Gross
NRX Pharmaceuticals, Inc. (NRXP) had Long-term Debt, Gross of $11.02 million as of 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2024-03-29
- 2023-12-31: Long-term Debt, Gross $11.02M.
- 2023-09-30: Long-term Debt, Gross $11.02M.
- 2023-06-30: Long-term Debt, Gross $11.02M.
- 2023-03-31: Long-term Debt, Gross $11.02M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2023-12-31 | $11.02M 10-K · filed 2024-03-29 |
| 2023-09-30 | $11.02M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $11.02M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $11.02M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $11.02M 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |